Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China · Delayed Price · Currency is CNY 15.43
-0.24 (-1.53%)
May 20, 2026, 11:29 AM CST
SHA:603858 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 373.94 | 360.78 | -553.8 | 318.97 | -1,530 | 1,289 |
Depreciation & Amortization | 514.3 | 514.3 | 450.25 | 592.57 | 497.56 | 510.43 |
Other Amortization | 7.3 | 7.3 | 219.62 | 64.71 | 38.19 | 3.48 |
Loss (Gain) From Sale of Assets | -0.16 | -0.16 | -0.43 | -1.53 | -0.77 | -1.68 |
Asset Writedown & Restructuring Costs | 527.97 | 527.97 | 855.33 | 602.34 | 2,944 | 12.42 |
Loss (Gain) From Sale of Investments | 283.33 | 283.33 | -12.87 | -18.94 | 54.06 | 42.39 |
Provision & Write-off of Bad Debts | -14.35 | -14.35 | -25.57 | 8.08 | 4.41 | 15.12 |
Other Operating Activities | -781.24 | -54.62 | 55.46 | -22.29 | 72.17 | 100.81 |
Change in Accounts Receivable | -684.54 | -684.54 | 583.89 | 83.68 | 483.36 | 363.14 |
Change in Inventory | -42.8 | -42.8 | 228.76 | -1,186 | 39.52 | -1,066 |
Change in Accounts Payable | 226.92 | 226.92 | -820.28 | -493.59 | 172.01 | 92.54 |
Operating Cash Flow | 444.32 | 1,158 | 939.95 | -195.61 | 2,756 | 1,321 |
Operating Cash Flow Growth | -71.22% | 23.18% | - | - | 108.68% | -32.58% |
Capital Expenditures | -102.55 | -123.42 | -197 | -529.92 | -543.17 | -433.53 |
Sale of Property, Plant & Equipment | 0.29 | 0.21 | 0.49 | 2.4 | 0.48 | 1.45 |
Cash Acquisitions | - | - | - | 0.75 | - | -272.7 |
Divestitures | - | - | -0 | -0.2 | - | -0.04 |
Investment in Securities | 130.3 | 69.04 | -63.55 | 328.37 | -478.96 | -46.91 |
Other Investing Activities | 117.08 | 12.14 | 10.51 | 30.6 | 11.47 | 96.05 |
Investing Cash Flow | 145.12 | -42.03 | -249.55 | -168 | -1,010 | -655.67 |
Long-Term Debt Issued | - | 1,848 | 2,306 | 1,505 | 2,295 | 3,173 |
Total Debt Issued | 2,612 | 1,848 | 2,306 | 1,505 | 2,295 | 3,173 |
Long-Term Debt Repaid | - | -1,961 | -1,905 | -1,355 | -2,722 | -3,154 |
Total Debt Repaid | -2,261 | -1,961 | -1,905 | -1,355 | -2,722 | -3,154 |
Net Debt Issued (Repaid) | 350.47 | -113.38 | 401.54 | 150.1 | -426.96 | 18.9 |
Repurchase of Common Stock | -0.63 | - | -702.34 | -9.99 | - | - |
Common Dividends Paid | -566.88 | -546.25 | -272.44 | -1,194 | -547.34 | -746.21 |
Other Financing Activities | -213.71 | -68.53 | 8.02 | -11.24 | -13.27 | -43.57 |
Financing Cash Flow | -430.75 | -728.16 | -565.21 | -1,065 | -987.57 | -770.88 |
Foreign Exchange Rate Adjustments | -0.11 | -0.08 | 0.01 | 0.01 | 0.16 | -0.34 |
Net Cash Flow | 158.58 | 387.52 | 125.2 | -1,429 | 758.04 | -106.38 |
Free Cash Flow | 341.77 | 1,034 | 742.96 | -725.52 | 2,212 | 886.98 |
Free Cash Flow Growth | -75.53% | 39.22% | - | - | 149.44% | -37.64% |
Free Cash Flow Margin | 2.93% | 8.71% | 6.75% | -5.48% | 14.80% | 5.63% |
Free Cash Flow Per Share | 0.32 | 0.98 | 0.69 | -0.66 | 2.00 | 0.80 |
Cash Interest Paid | - | - | - | - | 5.02 | - |
Cash Income Tax Paid | - | - | 1,419 | 1,819 | 1,915 | 2,308 |
Levered Free Cash Flow | 1,956 | 2,374 | 1,368 | -558.66 | 1,955 | 915.43 |
Unlevered Free Cash Flow | 1,957 | 2,374 | 1,449 | -489.95 | 2,040 | 1,020 |
Change in Working Capital | -466.78 | -466.78 | -48.05 | -1,740 | 675.49 | -651.7 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.